Mobile Phone-based Smoking Cessation Program

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

2000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2023-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this online, randomized controlled trial (RCT), the participants will be randomized and allocated in 1:1 ratio to mobile phone-based intervention group or to the wait-list control group. Participants will receive a 12-week intervention with follow-up at week 26. The primary outcome includes biologically verified continuous smoking abstinence at week 26 after the quit date. The main secondary outcomes include seven-day point prevalence smoking abstinence at weeks 1, 2, 3, 4, 8, 12, 16, 20 and 26, self-reported continuous smoking abstinence at weeks 4, 8, 12, 16, 20 and 26 after the quit date. About 2000 smokers with willingness to make a quit attempt within a month from October 2022 to April 2023 or until the recruitment process is complete will be recruited. The final 26-week follow-up will be completed in November 2023. The trial results will be available by the end of 2023 .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients

NCT06187142

Smoking Cessation

ACTIVE_NOT_RECRUITING NA

Boosting Chinese Healthcare Service Providers' Utilization of Smoking Cessation Interventions by 'WeChat WeQuit' Program

NCT03556774

Smoking Cessation Intervention Smoking Abstinence

UNKNOWN NA

Trial of An Innovative Smartphone Intervention for Smoking Cessation

NCT02724462

Smoking

COMPLETED NA

'WeChat WeQuit' Smoking Cessation Program

NCT03169686

Cigarette Smoking Smoking Cessation

COMPLETED NA

Efficacy of Smartphone App for Smoking Cessation in China

NCT04421170

Cigarette Smoking Smartphone App-based Smoking Cessation

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use Disorder (SUD)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

the wait-list control group

Group Type NO_INTERVENTION

No interventions assigned to this group

mobile phone-based intervention group

Participants will receive a 12-week intervention with follow-up at week 26.

Group Type EXPERIMENTAL

mobile phone-based intervention

Intervention Type OTHER

Participants in intervention group will receive a 12-week mobile phone-based intervention with follow-up at week 26.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mobile phone-based intervention

Participants in intervention group will receive a 12-week mobile phone-based intervention with follow-up at week 26.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* In this RCT, approximately 2,000 smokers (a smoker is defined as an individual who smoked 100 cigarettes in their lifetime, and currently smoke ≥ 5 cigarettes per day) who are willing to make a quit attempt within one month with CVDs diagnosis or risk.